Literature DB >> 22024597

Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases.

Joshua A Smith1, Arabinda Das, Swapan K Ray, Naren L Banik.   

Abstract

Microglia are activated in response to a number of different pathological states within the CNS including injury, ischemia, and infection. Microglial activation results in their production of pro-inflammatory cytokines such as IL-1, IL-6, and TNF-α. While release of these factors is typically intended to prevent further damage to CNS tissue, they may also be toxic to neurons and other glial cells. Mounting evidence indicates that chronic microglial activation may also contribute to the development and progression of neurodegenerative disorders. Unfortunately, determining the role of pro-inflammatory cytokines in these disorders has been complicated by their dual roles in neuroprotection and neurodegeneration. The purpose of this review is to summarize current understanding of the involvement of cytokines in neurodegenerative disorders and their potential signaling mechanisms in this context. Taken together, recent findings suggest that microglial activation and pro-inflammatory cytokines merit interest as targets in the treatment of neurodegenerative disorders. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22024597     DOI: 10.1016/j.brainresbull.2011.10.004

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  313 in total

1.  Biomarkers of Systemic Inflammation and Risk of Incident Hearing Loss.

Authors:  Shruti Gupta; Sharon G Curhan; Gary C Curhan
Journal:  Ear Hear       Date:  2019 Jul/Aug       Impact factor: 3.570

2.  IL-1β Induces MMP-9-Dependent Brain Astrocytic Migration via Transactivation of PDGF Receptor/NADPH Oxidase 2-Derived Reactive Oxygen Species Signals.

Authors:  Chuen-Mao Yang; Hsi-Lung Hsieh; Ping-Hsien Yu; Chih-Chung Lin; Shiau-Wen Liu
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

3.  Complement Components Are Expressed by Infiltrating Macrophages/Activated Microglia Early Following Viral Infection.

Authors:  Jane E Libbey; Matthew F Cusick; Daniel J Doty; Robert S Fujinami
Journal:  Viral Immunol       Date:  2017-04-12       Impact factor: 2.257

4.  Homeostatic interferon expression in neurons is sufficient for early control of viral infection.

Authors:  Sarah E Cavanaugh; Alicia M Holmgren; Glenn F Rall
Journal:  J Neuroimmunol       Date:  2014-12-16       Impact factor: 3.478

5.  Prevalence of Medical and Psychiatric Comorbidities Following Traumatic Brain Injury.

Authors:  Flora M Hammond; John D Corrigan; Jessica M Ketchum; James F Malec; Kristen Dams-OʼConnor; Tessa Hart; Thomas A Novack; Jennifer Bogner; Marie N Dahdah; Gale G Whiteneck
Journal:  J Head Trauma Rehabil       Date:  2019 Jul/Aug       Impact factor: 2.710

Review 6.  The effects of estrogen in ischemic stroke.

Authors:  Edward C Koellhoffer; Louise D McCullough
Journal:  Transl Stroke Res       Date:  2012-12-07       Impact factor: 6.829

7.  Pain in the Developing Brain: Early Life Factors Alter Nociception and Neurobiological Function in Adolescent Rats.

Authors:  Sabrina Salberg; Glenn R Yamakawa; Yannick Griep; Jesse Bain; Jaimie K Beveridge; Mujun Sun; Stuart J McDonald; Sandy R Shultz; Rhys D Brady; David K Wright; Melanie Noel; Richelle Mychasiuk
Journal:  Cereb Cortex Commun       Date:  2021-02-24

8.  Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells.

Authors:  Erika M Palmieri; Alessio Menga; Aurore Lebrun; Douglas C Hooper; D Allan Butterfield; Massimiliano Mazzone; Alessandra Castegna
Journal:  Antioxid Redox Signal       Date:  2016-11-02       Impact factor: 8.401

9.  Burn-Induced Microglia Activation is Associated With Motor Neuron Degeneration and Muscle Wasting in Mice.

Authors:  Li Ma; Yinhui Zhou; Mohammed A S Khan; Shingo Yasuhara; J A Jeevendra Martyn
Journal:  Shock       Date:  2019-05       Impact factor: 3.454

Review 10.  Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.

Authors:  Elvira Valera; Brian Spencer; Eliezer Masliah
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.